Does Isavuconazonium Sulfate Solution, Reconstituted (Recon Soln) Interact with other Medications?
Severe Interactions
These medications are not usually taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- ISAVUCONAZONIUM; VORICONAZOLE/SELECTED CYP3A4 INDUCERS
- ISAVUCONAZONIUM/PHENYTOIN
- ISAVUCONAZONIUM/SELECTED STRONG CYP3A4 INHIBITORS
- MODERATE CYP3A4 INHIBITORS/DARIDOREXANT (>25 MG)
- MODERATE CYP3A4 INHIBITORS/LUMATEPERONE (>21 MG)
- MODERATE CYP3A4 INHIBITORS/MITAPIVAT (> 20 MG)
- STRONG AND MODERATE CYP3A4 INHIBITORS/LONAFARNIB
- SLT STRONG & MODERATE CYP3A4 INHIBITORS/CILOSTAZOL (>50MG)
- SELECTED CYP3A4 MODERATE INHIBITORS/LURASIDONE (> 80 MG)
- STRONG AND MODERATE CYP3A4 INHIBITORS/ASUNAPREVIR
- STRONG OR MODERATE CYP3A4 INHIBITORS/LOMITAPIDE
- MODERATE CYP3A4 INHIBITORS/NALOXEGOL (> 12.5 MG)
- MODERATE CYP3A4 INHIBITORS/RANOLAZINE (> 500 MG BID)
- MODERATE CYP3A4 INHIBITORS/AVANAFIL (> 50 MG)
- STRONG OR MODERATE CYP3A4 INHIBITORS/FLIBANSERIN
- SELECTED CYP3A4 INHIBITORS/VARDENAFIL (> 5 MG)
Serious Interactions
These medications may interact and cause very harmful effects. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- ISAVUCONAZONIUM/RITONAVIR
- SLT SENSITIVE 3A4 SUBSTRATES THAT INHIBIT 3A4/ORAL LEFAMULIN
- SELECTED AZOLE ANTIFUNGAL CYP3A4 SUBSTRATES/ENASIDENIB
- P-GLYCOPROTEIN (P-GP) INHIBITORS/VINCRISTINE
- STRONG AND MODERATE CYP3A4 INHIBITORS/NIROGACESTAT
- STRONG AND MODERATE CYP3A4 INHIBITORS/REPOTRECTINIB
- MODERATE CYP3A4 INHIBITORS/LURBINECTEDIN
- SELECTED MODERATE CYP3A4 INHIBITORS/DOMPERIDONE
- MODERATE CYP3A4 INHIBITORS/COLCHICINE (FOR CARDIOPROTECTION)
- MODERATE CYP3A4 INHIBITORS/OMAVELOXOLONE
- STRONG AND MODERATE CYP3A4 INHIBITORS/ELACESTRANT
- MODERATE CYP3A4 INHIBITORS/PEXIDARTINIB
- SELECTED AZOLE ANTIFUNGAL AGENTS/TACROLIMUS
- MODERATE CYP3A4 INHIBITORS/MAVACAMTEN
- MODERATE CYP3A4 INHIBITORS/PACRITINIB
- MODERATE CYP3A4 INHIBITORS/MOBOCERTINIB
- STRONG AND MODERATE CYP3A4 INHIBITORS/FEXINIDAZOLE
- STRONG AND MODERATE CYP3A4 INHIBITORS/INFIGRATINIB
- SELECTED MODERATE CYP3A4 INHIBITORS/ALPRAZOLAM
- MODERATE CYP3A4 INHIBITORS/VOCLOSPORIN
- STRONG AND MODERATE CYP3A4 INHIBITORS/PRALSETINIB
- MODERATE CYP3A4 INHIBITORS/SELPERCATINIB
- MODERATE CYP3A4 INHIBITORS/PEXIDARTINIB (200 MG)
- STRONG AND MODERATE CYP3A4 INHIBITORS/PEMIGATINIB
- STRONG AND MODERATE CYP3A4 INHIBITORS/SELUMETINIB
- MODERATE CYP3A4 INHIBITORS/TAZEMETOSTAT
- STRONG AND MODERATE CYP3A4 INHIBITORS/LEMBOREXANT
- MODERATE CYP3A4 INHIBITORS/ELEXACAFTOR-TEZACAFTOR-IVACAFTOR
- MODERATE CYP3A4 INHIBITORS/ENTRECTINIB
- MODERATE CYP3A4 INHIBITORS/BRIGATINIB
- STRONG AND MODERATE CYP3A4 INHIBITORS/TEZACAFTOR-IVACAFTOR
- STRONG CYP3A4 INHIB;MODERATE 3A4 & P-GP DUAL INHIB/NERATINIB
- STRONG AND MODERATE CYP3A4 INHIBITORS/DEFLAZACORT
- MODERATE CYP3A4 INHIBITORS/VENETOCLAX
- SELECTED INHIBITORS OF P-GP OR BCRP/PAZOPANIB
- MODERATE CYP3A4 INHIBITORS/NALOXEGOL (<= 12.5 MG)
- MODERATE CYP3A4 INHIBITORS/COBIMETINIB; OLAPARIB; SONIDEGIB
- SELECTED P-GP AND MODERATE CYP3A4 INHIBITORS/RIVAROXABAN
- STRONG & MODERATE CYP3A4 INHIBITORS/ELIGLUSTAT
- MODERATE CYP3A4 INHIBITORS/SUVOREXANT (> 10 MG)
- MODERATE CYP3A4 INHIBITORS/ERGOT ALKALOIDS
- SELECTED MODERATE CYP3A4 INHIBITORS/PIMOZIDE
- STRONG & MODERATE CYP3A4 INHIBITORS/GUANFACINE
- STRONG OR MODERATE CYP3A4 INHIBITORS/SIMEPREVIR
- STRONG AND MODERATE CYP3A4 INHIBITORS/BOSENTAN
- MODERATE CYP3A4 INHIBITORS/BOSUTINIB
- STRONG AND MODERATE CYP3A4 INHIBITORS/IVACAFTOR
- MODERATE CYP3A4 INHIBITORS/COLCHICINE
- MODERATE CYP3A4 INHIBITORS/TOLVAPTAN
- P-GLYCOPROTEIN (P-GP) INHIBITORS/TOPOTECAN
- STRONG CYP3A4 INHIBITORS/MARAVIROC
- MODERATE CYP3A4 INHIBITORS/IVABRADINE
- SELECTED MODERATE CYP3A4 INHIBITORS/EPLERENONE
- SELECTED AZOLE ANTIFUNGAL AGENTS/SELECTED IMMUNOSUPPRESSANTS
Moderate Interactions
These medications may cause some risk when taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- SELECTED SENSITIVE CYP3A4 SUBSTRATES/SCHISANDRA
- MODERATE CYP3A4 INHIBITORS/MACITENTAN
- MODERATE CYP3A4 INHIBITORS/FINERENONE
- MODERATE CYP3A4 INHIBITORS/CAPIVASERTIB
- STRONG AND MODERATE CYP3A4 INHIBITORS/ETRASIMOD
- MODERATE CYP3A4 INHIBITORS/GEPIRONE
- MODERATE CYP3A4 INHIBITORS/PALOVAROTENE
- MODERATE CYP3A4 INHIBITORS/LAROTRECTINIB
- MODERATE CYP3A4 INHIBITORS/LUMATEPERONE (<=21 MG)
- MODERATE CYP3A4 INHIBITORS/MITAPIVAT (<= 20 MG)
- MODERATE CYP3A4 INHIBITORS/DARIDOREXANT (<=25 MG)
- STRONG OR MODERATE CYP2D6 OR CYP3A4 INHIBITORS/OLICERIDINE
- CYP2B6 AND SELECTED CYP3A4 INDUCERS/LEVOMETHADONE; METHADONE
- MODERATE CYP3A4 INHIBITORS/RIMEGEPANT
- MODERATE CYP3A4 INHIBITORS/AVAPRITINIB
- MODERATE CYP3A4 INHIBITORS/UBROGEPANT
- MODERATE CYP3A4 INHIBITORS/ZANUBRUTINIB
- SELECTED CYP3A4 MODERATE INHIBITORS/LURASIDONE (<= 80 MG)
- MODERATE CYP3A4 INHIBITORS/ABEMACICLIB
- MODERATE CYP3A4 INHIBITORS/CABERGOLINE
- SELECTED MODERATE CYP3A4 INHIBITORS/ACALABRUTINIB
- MODERATE CYP3A4 INHIBITORS/QUETIAPINE
- MODERATE CYP3A4 INHIBITORS/BROMOCRIPTINE
- MODERATE CYP3A4 INHIBITORS/BREXPIPRAZOLE
- ISAVUCONAZONIUM/DIGOXIN
- P-GP AND MODERATE CYP3A4 INHIBITORS/APIXABAN
- P-GP AND SELECTED CYP3A4 INHIBITORS/NINTEDANIB
- MODERATE CYP3A4 INHIBITORS/SUVOREXANT (<= 10 MG)
- MODERATE CYP3A4 INHIBITORS/AVANAFIL (<= 50 MG)
- MODERATE CYP3A4 INHIBITORS/IBRUTINIB
- P-GLYCOPROTEIN (P-GP) INHIBITORS/AFATINIB
- SELECTED CYP3A4 INHIBITORS/VARDENAFIL (<= 5 MG)
- SELECTED MODERATE CYP3A4 INHIBITORS/SELECTED OPIOIDS
- MODERATE CYP3A4; P-GP INHIBITORS/EVEROLIMUS
- MODERATE CYP3A4 INHIBITORS/RANOLAZINE (<=500 MG BID)
- CYP3A4; CYP2C8; P-GLYCOPROTEIN (P-GP) INHIBITORS/LOPERAMIDE
- SLT STRONG & MODERATE CYP3A4 INHIBITORS/CILOSTAZOL (<=50MG)
Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.
CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.